“We recognize that those with rare diseases often have complex needs that go unmet by traditional assistance,” said Green.

Global biotechnology leader CSL has announced that the European Commission (EC) has approved ANDEMBRY (garadacimab), the ...

Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) today announced that the European Commission (EC) has approved ...

Abstract Title: Briquilimab Potently Inhibits Stem Cell Factor (SCF)/c-Kit Signaling and Induces Mast Cell Apoptosis Poster Number: 541 Session Title: Novel Mechanisms of Mast Cells, Basophils and IgE ...

A spirometry test is one way to distinguish the type of lung disease. Emphysema and chronic bronchitis are both long-term lung conditions. They’re part of a disorder known as chronic obstructive ...

Angioedema is a well-known side effect of treatment with an angiotensin-converting enzyme (ACE) inhibitor and one that we have been willing to accept in view of the incidence of the problem and ...

The National Institute of Mental Health defines chronic disease as “a condition that lasts at least one year and requires ongoing medical attention or limits activities of daily living or both.” ...